Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance (DOI:10.1016/j.ccr.2006.04.023);Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

Cancer Cell

Volumn 9, Issue 6, 2006, Pages 425-434

  Fantin, Valeria R ^a   St Pierre, Julie ^b   Leder, Philip ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE ISOENZYME; LACTIC ACID; PYRUVIC ACID; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME REPRESSION; FLOW CYTOMETRY; GLYCOLYSIS; HYPOXIA; MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAINING; TUMOR CELL; TUMOR GROWTH;

EID: 33744783432     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.07.011     Document Type: Erratum

References (44)

1. Aft R.L., Zhang F.W., and Gius D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br. J. Cancer 87 (2002) 805-812
2. Ainscow E.K., Zhao C., and Rutter G.A. Acute overexpression of lactate dehydrogenase-A perturbs β-cell mitochondrial metabolism and insulin secretion. Diabetes 49 (2000) 1149-1155
3. Balinsky D., Platz C.E., and Lewis J.W. Isozyme patterns of normal, benign, and malignant human breast tissues. Cancer Res. 43 (1983) 5895-5901
4. Brand M. Chapter 3: Measurement of mitochondrial protonmotive force. In: Brown G., and Cooper C. (Eds). Bioenergetics-A Practical Approach (1995), Oxford University Press, Oxford 39-62
5. Bergmeyer H.U. In: Bergmeyer J., and Graßl M. (Eds). Methods of Enzymatic Analysis (1984), Verlag Chemie, Weinheim, Germany 570-588
6. Brand K. Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J. Bioenerg. Biomembr. 29 (1997) 355-364
7. Brand K.A., and Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11 (1997) 388-395
8. Capuano F., Guerrieri F., and Papa S. Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J. Bioenerg. Biomembr. 29 (1997) 379-384
9. Chen L.B. Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol. 4 (1988) 155-181
10. Conley K.E., Kemper W.F., and Crowther G.J. Limits to sustainable muscle performance: interaction between glycolysis and oxidative phosphorylation. J. Exp. Biol. 204 (2001) 3189-3194
11. Costantini P., Jacotot E., Decaudin D., and Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. 92 (2000) 1042-1053
12. Cuezva J.M., Krajewska M., de Heredia M.L., Krajewski S., Santamaria G., Kim H., Zapata J.M., Marusawa H., Chamorro M., and Reed J.C. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 62 (2002) 6674-6681
13. Dang C.V., and Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24 (1999) 68-72
14. Dorward A., Sweet S., Moorehead R., and Singh G. Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance. J. Bioenerg. Biomembr. 29 (1997) 385-392
15. Fantin V.R., Berardi M.J., Scorrano L., Korsmeyer S.J., and Leder P. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell 2 (2002) 29-42
16. Fialka I., Schwarz H., Reichmann E., Oft M., Busslinger M., and Beug H. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J. Cell Biol. 132 (1996) 1115-1132
17. Gatenby R.A., and Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 4 (2004) 891-899
18. Golshani-Hebroni S.G., and Bessman S.P. Hexokinase binding to mitochondria: a basis for proliferative energy metabolism. J. Bioenerg. Biomembr. 29 (1997) 331-338
19. Greiner E.F., Guppy M., and Brand K. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 269 (1994) 31484-31490
20. Heerdt B.G., Houston M.A., Wilson A.J., and Augenlicht L.H. The intrinsic mitochondrial membrane potential (Deltapsim) is associated with steady-state mitochondrial activity and the extent to which colonic epithelial cells undergo butyrate-mediated growth arrest and apoptosis. Cancer Res. 63 (2003) 6311-6319
21. Hilf R., Rector W.D., and Orlando R.A. Multiple molecular forms of lactate dehydrogenase and glucose 6-phosphate dehydrogenase in normal and abnormal human breast tissues. Cancer 37 (1976) 1825-1830
22. Isidoro A., Martinez M., Fernandez P.L., Ortega A.D., Santamaria G., Chamorro M., Reed J.C., and Cuezva J.M. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem. J. 378 (2004) 17-20
23. Kanno T., Sudo K., Maekawa M., Nishimura Y., Ukita M., and Fukutake K. Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy. Clin. Chim. Acta 173 (1988) 89-98
24. Koukourakis M.I., Giatromanolaki A., and Sivridis E. Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol. 24 (2003) 199-202
25. Lewis B.C., Prescott J.E., Campbell S.E., Shim H., Orlowski R.Z., and Dang C.V. Tumor induction by the c-Myc target genes rcl and lactate dehydrogenase A. Cancer Res. 60 (2000) 6178-6183
26. Liang B.C., Miller L., and Weller A. Ethyl-nitrosourea transformed astrocytes exhibit mitochondrial membrane hyperpolarization and constrained apoptosis. Apoptosis 4 (1999) 89-97
27. Lopez-Barahona M., Fialka I., Gonzalez-Sancho J.M., Asuncion M., Gonzalez M., Iglesias T., Bernal J., Beug H., and Munoz A. Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells. EMBO J. 14 (1995) 1145-1155
28. Mathupala S.P., Rempel A., and Pedersen P.L. Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J. Bioenerg. Biomembr. 29 (1997) 339-343
29. Mazurek S., and Eigenbrodt E. The tumor metabolome. Anticancer Res. 23 (2003) 1149-1154
30. Modica-Napolitano J.S., and Aprille J.R. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug Deliv. Rev. 49 (2001) 63-70
31. Oft M., Peli J., Rudaz C., Schwarz H., Beug H., and Reichmann E. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10 (1996) 2462-2477
32. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., and Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16 (2002) 948-958
33. Plas D.R., and Thompson C.B. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13 (2002) 75-78
34. Ramanathan A., Wang C., and Schreiber S.L. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. USA 102 (2005) 5992-5997
35. Reichmann E., Ball R., Groner B., and Friis R.R. New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J. Cell Biol. 108 (1989) 1127-1138
36. Reichmann E., Schwarz H., Deiner E.M., Leitner I., Eilers M., Berger J., Busslinger M., and Beug H. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71 (1992) 1103-1116
37. Richards A.H., and Hilf R. Influence of pregnancy, lactation and involution on glucose-6-phosphate dehydrogenase and lactate dehydrogenase in the rat mammary gland. Endocrinology 91 (1972) 287-295
38. Rolfe D.F., and Brown G.C. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol. Rev. 77 (1997) 731-758
39. Sekine N., Cirulli V., Regazzi R., Brown L.J., Gine E., Tamarit-Rodriguez J., Girotti M., Marie S., MacDonald M.J., Wollheim C.B., et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cells. Potential role in nutrient sensing. J. Biol. Chem. 269 (1994) 4895-4902
40. Semenza G.L., Artemov D., Bedi A., Bhujwalla Z., Chiles K., Feldser D., Laughner E., Ravi R., Simons J., Taghavi P., and Zhong H. 'The metabolism of tumours': 70 years later. Novartis Found. Symp. 240 (2001) 251-260
41. Shim H., Dolde C., Lewis B.C., Wu C.S., Dang G., Jungmann R.A., Dalla-Favera R., and Dang C.V. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94 (1997) 6658-6663
42. Stockwell B.R., Haggarty S.J., and Schreiber S.L. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6 (1999) 71-83
43. Warburg O. The Metabolism of Tumors (1930), Arnold Constable, London
44. Zarbl H., Latreille J., and Jolicoeur P. Revertants of v-fos-transformed fibroblasts have mutations in cellular genes essential for transformation by other oncogenes. Cell 51 (1987) 357-369